Abstract
Backgrounds/Aims
Prognostic factors for colorectal cancer with hepatic metastasis are not well-established. We investigated the factors that predicted survival following surgical resection of hepatic metastases in patients with colorectal cancer.
Methods
Fifty-three patients underwent resection of hepatic metastases of colorectal cancer between January 2000 and December 2005, with follow-up periods that ranged from 3 to 119 months. In this retrospective study, the effects of sex, age, type of hepatic resection, T stage and N stage of the primary cancer, number and size of metastatic hepatic tumors, synchronicity or metachronicity of the liver metastases, surgical resection margins, and preoperative carcinoembryonic antigen (CEA) levels on 1-year and 3-year survival were analyzed using the Kaplan-Meier method and the log rank test.
Results
Median survival was 39.9 months and the 3-year survival rate was 62.2%. Twenty patients died during the follow-up period of 3 to 119 months (mean, 48.8±34.24). In univariate analysis, only the surgical margin of the hepatic metastasis resection correlated significantly with 3-year survival. Sex, age, T stage and N stage of the primary cancer, synchronicity or metachronicity of the metastases, number and size of hepatic metastases, type of hepatic resection and preoperative CEA levels did not predict long-term outcome.
References
1. Benson AB 3rd. Epidemiology, disease progression, and economic burden of colorectal cancer. J Manag Care Pharm. 2007. 13:6 Suppl C. S5–S18.
2. Taylor I. Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br J Surg. 1996. 83:456–460.
3. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990. 77:1241–1246.
4. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002. 235:759–766.
5. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995. 19:59–71.
6. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999. 230:309–318.
7. Nordlinger B, Guiguet M, Vaillant JC, et al. Association Franaise de Chirurgie. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996. 77:1254–1262.
8. Leveson SH, Wiggins PA, Giles GR, et al. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg. 1985. 72:128–130.
9. Gilbert HA, Kagan AR. Weiss L, editor. Metastases: incidence, detection, and evaluation without histologic confirmation. Fundamental aspects of metastases. 1976. Amsterdam: North Holland Publishing Co;385–405.
10. Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984. 199:502–508.
11. Scheele J, Rudroff C, Altendorf-Hofmann A. Resection of colorectal liver metastases revisited. J Gastrointest Surg. 1997. 1:408–422.
12. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994. 116:703–710.
13. Adson MA. Resection of liver metastases--when is it worthwhile? World J Surg. 1987. 11:511–520.
14. Holm A, Bradley E, Aldrete JS. Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg. 1989. 209:428–434.
15. Youn SM, Heo JS, Choi DW, et al. Comparative outcome after treatment for synchronous vs. Metachronous colorectal cancer liver metastasis. Korean J Hepatobiliary Pancreat Surg. 2010. 14:154–164.
16. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg. 1985. 201:204–209.
17. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery. 1988. 103:278–288.
18. Ahn SW, Na AS, Yang JD, et al. Scoring of prognostic factors that influence long-term survival in patients with hepatic metastasis of colorectal cancer. Korean J Hepatobiliary Pancreat Surg. 2011. 15:146–151.
19. Cady B, Stone MD, McDermott WV Jr, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg. 1992. 127:561–568.
20. Oussoultzoglou E, Rosso E, Fuchshuber P, et al. Perioperative carcinoembryonic antigen measurements to predict curability after liver resection for colorectal metastases: a prospective study. Arch Surg. 2008. 143:1150–1158.
21. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg. 1991. 214:107–113.
22. Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991. 78:797–801.
23. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998. 227:566–571.